Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Safety outcomes by baseline MRA use
| Safety outcomes, n (%) | Baseline MRA use |
No baseline MRA use |
||
|---|---|---|---|---|
| Dapagliflozin (n = 109) | Placebo (n = 120) | Dapagliflozin (n = 2040) | Placebo (n = 2029) | |
| Study drug discontinuation because of adverse event | 4 (3.7) | 6 (5.0) | 114 (5.6) | 117 (5.8) |
| Any serious adverse eventa | 43 (39.4) | 51 (42.5) | 551 (27.0) | 623 (30.7) |
MRA, mineralocorticoid receptor antagonist.
Includes death; safety outcomes were analyzed in the safety population (N = 4298).
